Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,443 | N/A | -18,520 | -8,889 | -3,669 |
| Depreciation Amortization | 156 | N/A | 484 | 326 | 167 |
| Accounts receivable | -71 | N/A | 72 | 68 | -187 |
| Accounts payable and accrued liabilities | 1,542 | N/A | -45 | 27 | 844 |
| Other Working Capital | 34 | N/A | -469 | -1,283 | 494 |
| Other Operating Activity | -3,762 | 0 | 3,508 | -1,317 | -2,340 |
| Operating Cash Flow | $-4,544 | $N/A | $-14,970 | $-11,068 | $-4,691 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | -87 | -87 | -87 |
| Investing Cash Flow | $-6 | $N/A | $-87 | $-87 | $-87 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 18,359 | N/A | N/A |
| Common Stock Repurchased | 10 | N/A | 30 | 6 | 6 |
| Financing Cash Flow | $10 | $N/A | $18,389 | $6 | $6 |
| Beginning Cash Position | 39,781 | N/A | 39,050 | 39,050 | 39,050 |
| End Cash Position | 35,241 | N/A | 42,382 | 27,901 | 34,278 |
| Net Cash Flow | $-4,540 | $N/A | $3,332 | $-11,149 | $-4,772 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,544 | N/A | -14,970 | -11,068 | -4,691 |
| Capital Expenditure | -6 | N/A | -87 | -87 | -87 |
| Free Cash Flow | -4,550 | 0 | -15,057 | -11,155 | -4,778 |